Gilead Sciences (GILD) Shares Outstanding (Entity) (2009 - 2026)
Gilead Sciences' Shares Outstanding (Entity) came in at 1.24 billion for Q2 2026, down 0.1% from 1.24 billion a year earlier and down 0.1% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends
Going back to Q1 2009, Gilead Sciences' Shares Outstanding (Entity) data covers 70 quarters.
- Shares Outstanding (Entity) carries a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 1.25 billion in FY2024 (unchanged), 1.25 billion in FY2023 (-0.1%), 1.25 billion in FY2022 (-0.6%) and 1.25 billion in FY2021 (unchanged).
- The five-year range for quarterly Shares Outstanding (Entity) is 1.24 billion (Q4 2025) to 1.26 billion (Q1 2022).
- Year-over-year, Shares Outstanding (Entity) has declined for six consecutive quarters, with an average decline of 0.2% over the last eight quarters.
- Business Quant data shows GILD's Shares Outstanding (Entity) at 1.24 billion (Q1 2026), 1.24 billion (Q4 2025) and 1.24 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 253.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Bn |
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.24 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.25 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.25 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.25 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 1.25 Bn |
| Jun 30, 2022 | 1.25 Bn |
| Mar 31, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Sep 30, 2021 | 1.26 Bn |
API Access
Gilead Sciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();